These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 19414570)
1. CMY-29 and CMY-30, two novel plasmid-mediated AmpC beta-lactamases. Pope CE; Carter PE; Heffernan HM Antimicrob Agents Chemother; 2009 Jul; 53(7):3178. PubMed ID: 19414570 [No Abstract] [Full Text] [Related]
2. Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China. Li Y; Li Q; Du Y; Jiang X; Tang J; Wang J; Li G; Jiang Y J Clin Microbiol; 2008 Apr; 46(4):1317-21. PubMed ID: 18305137 [TBL] [Abstract][Full Text] [Related]
3. Characterization of blaCMY-11, an AmpC-type plasmid-mediated beta-lactamase gene in a Korean clinical isolate of Escherichia coli. Lee SH; Kim JY; Lee GS; Cheon SH; An YJ; Jeong SH; Lee KJ J Antimicrob Chemother; 2002 Feb; 49(2):269-73. PubMed ID: 11815567 [TBL] [Abstract][Full Text] [Related]
4. Two novel CMY-2-type β-lactamases encountered in clinical Escherichia coli isolates. Manageiro V; Ferreira E; Pinto M; Fonseca F; Ferreira M; Bonnet R; Caniça M Ann Clin Microbiol Antimicrob; 2015 Mar; 14():12. PubMed ID: 25885413 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of phenotypic screening methods for detecting plasmid-mediated AmpC beta-lactamases-producing isolates of Escherichia coli and Klebsiella pneumoniae. Lee K; Hong SG; Park YJ; Lee HS; Song W; Jeong J; Yong D; Chong Y Diagn Microbiol Infect Dis; 2005 Dec; 53(4):319-23. PubMed ID: 16269222 [TBL] [Abstract][Full Text] [Related]
6. CMY-2, CMY-8b, and DHA-1 plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from a university hospital, Thailand. Singtohin S; Chanawong A; Lulitanond A; Sribenjalux P; Auncharoen A; Kaewkes W; Songsri J; Pienthaweechai K Diagn Microbiol Infect Dis; 2010 Nov; 68(3):271-7. PubMed ID: 20851550 [TBL] [Abstract][Full Text] [Related]
7. Extended-spectrum beta-lactam resistance due to AmpC hyperproduction and CMY-2 coupled with the loss of OMPK35 in Malaysian strains of Escherichia coli and Klebsiella pneumoniae. Palasubramaniam S; Subramaniam G; Muniandy S; Parasakthi N Microb Drug Resist; 2007; 13(3):186-90. PubMed ID: 17949305 [TBL] [Abstract][Full Text] [Related]
8. The prevalence of plasmid-mediated AmpC beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children's hospitals in China. Ding H; Yang Y; Lu Q; Wang Y; Chen Y; Deng L; Wang A; Deng Q; Zhang H; Wang C; Liu L; Xu X; Wang L; Shen X Eur J Clin Microbiol Infect Dis; 2008 Oct; 27(10):915-21. PubMed ID: 18449580 [TBL] [Abstract][Full Text] [Related]
9. [Detection of plasmid-mediated AmpC beta-lactamase in clinical isolates of cefoxitin-resistant Escherichia coli and Klebsiella pneumoniae]. Coşkun S; Altanlar N Mikrobiyol Bul; 2012 Jul; 46(3):375-85. PubMed ID: 22951650 [TBL] [Abstract][Full Text] [Related]
10. Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway. Naseer U; Haldorsen B; Simonsen GS; Sundsfjord A Clin Microbiol Infect; 2010 Feb; 16(2):171-8. PubMed ID: 19548922 [TBL] [Abstract][Full Text] [Related]
11. Emerging problems with plasmid-mediated DHA and CMY AmpC beta-lactamases in Enterobacteriaceae in Singapore. Koh TH; Sng LH; Wang G; Hsu LY; Lin RT; Tee NW Int J Antimicrob Agents; 2007 Sep; 30(3):278-80. PubMed ID: 17587551 [No Abstract] [Full Text] [Related]
12. CMY-42, a novel plasmid-mediated CMY-2 variant AmpC beta-lactamase. Hentschke M; Kotsakis SD; Wolters M; Heisig P; Miriagou V; Aepfelbacher M Microb Drug Resist; 2011 Jun; 17(2):165-9. PubMed ID: 21388298 [TBL] [Abstract][Full Text] [Related]
13. Prevalence study of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking inducible ampC from Saudi hospitals. Abdalhamid B; Albunayan S; Shaikh A; Elhadi N; Aljindan R J Med Microbiol; 2017 Sep; 66(9):1286-1290. PubMed ID: 28820112 [TBL] [Abstract][Full Text] [Related]
14. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials. Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039 [TBL] [Abstract][Full Text] [Related]
15. In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime. Pires J; Taracila M; Bethel CR; Doi Y; Kasraian S; Tinguely R; Sendi P; Bonomo RA; Endimiani A Antimicrob Agents Chemother; 2015 Dec; 59(12):7483-8. PubMed ID: 26392491 [TBL] [Abstract][Full Text] [Related]
16. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin]. Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075 [TBL] [Abstract][Full Text] [Related]
17. Extended-spectrum beta-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan. Yan JJ; Hsueh PR; Lu JJ; Chang FY; Shyr JM; Wan JH; Liu YC; Chuang YC; Yang YC; Tsao SM; Wu HH; Wang LS; Lin TP; Wu HM; Chen HM; Wu JJ Antimicrob Agents Chemother; 2006 May; 50(5):1861-4. PubMed ID: 16641462 [TBL] [Abstract][Full Text] [Related]
18. [Investigation of plasmid mediated AmpC beta-lactamases among Escherichia coli and Klebsiella pneumoniae isolated from blood cultures]. Sarı AN; Biçmen M; Gülay Z Mikrobiyol Bul; 2013 Oct; 47(4):582-91. PubMed ID: 24237427 [TBL] [Abstract][Full Text] [Related]